Single Ventricle Palliation #1: Pre-Stage I Physiology and Pulmonary Artery Banding

Date
September 18, 2026
URL
https://x.com/WithAScalpel/status/2100919319152452058?s=20
Categories
Single Ventricle

Single Ventricle Palliation #1: Pre–Stage I Physiology and Pulmonary Artery Banding

image

Functionally single-ventricle physiology encompasses a heterogeneous group of congenital heart lesions in which one ventricular chamber effectively supports both pulmonary and systemic circulations. Before cavopulmonary connection, these circulations operate largely in parallel rather than in series. Consequently, the clinical problem is not simply whether total ventricular output is adequate, but how that output is partitioned between pulmonary blood flow (Qp) and systemic blood flow (Qs). The pre–Stage I circulation therefore depends on the anatomy of systemic and pulmonary outflow, the adequacy of intracardiac mixing, and the relative pulmonary and systemic vascular resistances. [1]

1. Parallel Circulation Before Stage I Palliation

In the simplified complete-mixing model, all systemic and pulmonary venous return enters a common functional ventricular pathway, and total single-ventricular output can be expressed as:

COsv = Qp + Qs

The same mixed blood is then distributed to the pulmonary and systemic vascular beds. Under true complete mixing, oxygen saturation in the pulmonary artery and aorta is therefore similar, and the ratio Qp/Qs primarily reflects the balance between pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR).

This model is useful but deliberately idealized. Complete mixing is not guaranteed in every functionally univentricular heart. Preferential streaming may occur according to atrial anatomy, ventricular geometry, atrioventricular valve relationships, and the origin of the great arteries. Thus, the practical interpretation of “PA saturation = aortic saturation” should be limited to lesions in which mixing is effectively complete before ventricular ejection. [1,2]

When ventricular and arterial pressures are shared and there is no important outflow obstruction, pulmonary and systemic flows are governed mainly by the relative downstream resistances. As neonatal PVR falls after birth, Qp tends to increase. Because total ventricular output is finite, excessive pulmonary flow may occur at the expense of Qs. A higher systemic arterial saturation can therefore coexist with worsening systemic perfusion; oxygen saturation alone is not a surrogate for systemic oxygen delivery. Theoretical and clinical analyses of complete-mixing physiology support assessing the circulation by flow balance and systemic venous oxygenation rather than attempting to maximize arterial saturation. [2]

2. Ductal Patency and Atrial Communication

The exact dependencies of the preoperative circulation are lesion-specific. In hypoplastic left heart syndrome (HLHS) with mitral and aortic atresia, the right ventricle ejects into the pulmonary artery, and systemic output reaches the aorta through the patent ductus arteriosus. Ductal patency is therefore obligatory until a durable systemic outflow pathway is created. Pulmonary venous blood must also cross an adequate atrial communication to reach the systemic ventricle; a restrictive or intact atrial septum produces pulmonary venous hypertension, severe hypoxemia, and rapid hemodynamic deterioration. [3]

Accordingly, stabilization of ductal-dependent systemic circulation requires preservation of the ductus, usually with prostaglandin E1, and confirmation that atrial egress is unrestricted. The third major variable is Qp/Qs. Lowering PVR excessively with unnecessary hyperoxia, marked alkalosis, or excessive ventilation can increase pulmonary runoff and reduce effective systemic flow. Conversely, excessive pulmonary vasoconstriction can produce unacceptable hypoxemia. The therapeutic target is therefore adequate systemic oxygen delivery rather than any isolated saturation value. [3,4]

Clinical assessment should integrate systemic blood pressure, pulse quality, capillary refill, urine output, lactate trend, systemic or central venous saturation when available, near-infrared spectroscopy, ventricular function, atrioventricular valve regurgitation, and echocardiographic evidence of systemic and pulmonary flow. This is particularly important because two infants with the same arterial saturation may have substantially different Qp/Qs and systemic oxygen delivery.

3. Pulmonary Overcirculation and Ventricular Volume Loading

When pulmonary blood flow is unrestricted and PVR falls, the single ventricle receives the systemic venous return plus the recirculated pulmonary venous return. The result is pulmonary overcirculation and disproportionate ventricular volume loading. The clinical manifestations include tachypnea, feeding intolerance, poor growth, pulmonary edema, atrioventricular valve regurgitation, and systemic hypoperfusion despite apparently satisfactory arterial oxygen saturation.

This physiology is especially undesirable in a patient expected to proceed toward cavopulmonary palliation. The future Fontan pathway requires a low-resistance pulmonary vascular bed. Prolonged exposure to excessive pulmonary flow and pressure promotes pulmonary vascular remodeling and may compromise later candidacy for bidirectional cavopulmonary connection and Fontan completion. [4,5] Thus, in lesions with unrestricted pulmonary blood flow but without an obligatory need for unrestricted antegrade pulmonary flow, early control of Qp is a central palliative objective.

4. Physiologic Rationale for Pulmonary Artery Banding

Pulmonary artery banding (PAB) introduces a fixed resistance between the ventricle and pulmonary vascular bed. Its primary physiologic effects are to restrict pulmonary blood flow, reduce distal pulmonary arterial pressure, protect the pulmonary microvasculature, and decrease pulmonary venous return. The latter reduces systemic ventricular volume loading. By redirecting a greater proportion of total ventricular output toward the systemic circulation, an appropriately restrictive band can also improve effective systemic perfusion. These are the central effects represented by the transition from the pre-PAB to post-PAB circulation.

For functionally single-ventricle lesions with unrestricted pulmonary blood flow, conventional main PAB remains a useful initial strategy in selected anatomies. Retrospective series have shown that patients can subsequently progress to bidirectional cavopulmonary connection and Fontan completion, including selected patients requiring concomitant arch reconstruction. [5-8] The evidence, however, is observational and heterogeneous; PAB should not be interpreted as a uniform first-stage operation for all single-ventricle anatomies.

The timing and degree of restriction must be individualized. A retrospective neonatal series found no advantage to waiting for PVR to fall before band placement in patients with unrestricted pulmonary flow and no systemic outflow obstruction, supporting early intervention when pulmonary overcirculation is already evident or predictable. [7] More restrictive neonatal banding followed by earlier cavopulmonary connection has also been associated with lower ventricular volume and lower pre-Glenn pulmonary vascular resistance in institutional series. [6] These data describe institutional strategies rather than universally validated numeric targets.

5. Anatomy That Limits the Use of Main Pulmonary Artery Banding

The principal question before conventional PAB is whether restricting the pulmonary outflow can jeopardize systemic output. In single-ventricle anatomy with a vulnerable systemic outflow pathway—particularly lesions in which systemic blood must traverse a ventricular septal defect or bulboventricular foramen before reaching the aorta—PAB can be problematic. Progressive ventricular hypertrophy and altered loading conditions may unmask or worsen subaortic obstruction. Patients with associated aortic arch obstruction may similarly require arch reconstruction and, in selected morphologies, a Damus–Kaye–Stansel connection or another strategy that secures systemic outflow. [5,8]

For this reason, the operation should be selected from the complete anatomic pathway rather than from the presence of pulmonary overcirculation alone. Preoperative imaging should define the systemic ventricular outlet, ventricular communication, semilunar valves, arch, pulmonary arteries, and atrioventricular valve competence.

6. Technical and Intraoperative Goals of Main PAB

The main pulmonary artery is usually banded sufficiently distal to the pulmonary valve to avoid valvar distortion but proximal enough to avoid branch pulmonary artery impingement. The band must remain stable and should not migrate toward either branch. The desired restriction cannot be defined reliably by one formula or Doppler velocity because the measured gradient depends on cardiac output, ventricular contractility, hemoglobin, anesthesia, PVR, and systemic vascular tone.

The intraoperative assessment is therefore multidimensional. The surgeon should assess systemic arterial pressure and perfusion, oxygen saturation, distal pulmonary arterial pressure when directly measured, ventricular function, atrioventricular valve regurgitation, band position, pulmonary valve competence, and branch pulmonary artery geometry. Transesophageal or epicardial echocardiography should confirm that the band is discrete and that neither branch pulmonary artery is distorted. A technically satisfactory gradient is not sufficient if systemic output deteriorates or ventricular function worsens.

7. Bilateral Pulmonary Artery Banding in HLHS

Bilateral pulmonary artery banding is physiologically different from conventional main PAB. In HLHS, the right ventricle must continue to eject through the main pulmonary artery and ductus arteriosus to supply the systemic circulation. Restriction is therefore placed on the right and left branch pulmonary arteries while preserving the main pulmonary artery–ductal pathway. The purpose is to limit Qp while maintaining ductal systemic output.

Importantly, bilateral PAB alone is not synonymous with a complete hybrid Stage I palliation. The established hybrid concept combines bilateral branch PA bands with maintenance of ductal patency—commonly by ductal stenting—and creation or maintenance of an unrestricted atrial communication when necessary. [9,10] In selected high-risk neonates, bilateral bands with continued prostaglandin infusion may also be used as a temporizing or resuscitative bridge before Norwood reconstruction, comprehensive Stage II, transplantation, or another definitive pathway. [11,12]

Technical precision is critical. The bands must produce reasonably balanced right and left pulmonary blood flow without compromising the central or lobar pulmonary arteries. Excessively tight or prolonged branch banding can produce focal stenosis and increase the need for later catheter or surgical pulmonary artery intervention. [13] Surveillance should therefore include branch PA dimensions and gradients, distal flow distribution, ductal patency, and the adequacy of retrograde aortic arch flow. In aortic atresia, obstruction of retrograde flow through the arch or isthmus may threaten coronary and cerebral perfusion and requires particularly close attention.

8. How to Interpret the Hybrid Strategy

Hybrid palliation can reduce the physiologic burden of an immediate neonatal Norwood operation in carefully selected patients, but it should not be presented as a universally superior alternative. The literature is strongly affected by selection bias because hybrid strategies are frequently used in smaller, premature, or otherwise high-risk neonates. Early institutional reports established technical feasibility and acceptable staged outcomes, whereas subsequent studies have documented important interstage attrition and reintervention requirements. [9-13]

A 2024 systematic review and meta-analysis of 21 studies found no overall survival advantage for hybrid palliation over Norwood palliation and reported more unplanned interventions in hybrid patients; interpretation remains limited by heterogeneous, nonrandomized cohorts. [14] (PubMed) More recent multicenter registry data in high-risk infants likewise support individualized selection rather than assuming that hybrid palliation improves outcome across all risk groups. [15] (PubMed) The practical value of bilateral PA banding is therefore as a physiologic tool: it can control pulmonary overcirculation and defer a larger reconstruction when the anatomy and clinical condition make that strategy advantageous.

Key Surgical and Clinical Principles

  • Before Stage I, the functionally single ventricle supports two parallel circulations; total ventricular output is Qp + Qs, and clinical stability depends on how that output is partitioned.
  • Under complete intracardiac mixing, pulmonary and systemic arterial saturations may be similar, but arterial saturation alone does not define systemic oxygen delivery.
  • In ductal-dependent systemic circulation, ductal patency and unrestricted atrial egress are prerequisites; Qp/Qs must then be balanced to preserve systemic perfusion.
  • Conventional main PAB is most appropriate when pulmonary blood flow is excessive and systemic outflow is secure.
  • PAB reduces Qp, distal PA pressure, pulmonary vascular exposure, and ventricular volume loading, but excessive restriction can impair oxygenation and cardiac output.
  • Bilateral PA banding in HLHS preserves the main PA–ductal systemic pathway while restricting branch pulmonary flow; when used as hybrid Stage I palliation, it must be integrated with secure ductal patency and adequate atrial communication.
  • Band position, symmetry, ventricular function, systemic perfusion, and branch PA geometry are more important than any isolated band gradient.
  • The hybrid pathway is a patient-selection strategy, not an established universal substitute for Norwood palliation.

References

  1. Nelson DP, Schwartz SM, Chang AC. Neonatal physiology of the functionally univentricular heart. Cardiol Young. 2004;14(Suppl 1):52-60. doi:10.1017/S1047951104006304. PMID: 15244140.
  2. Francis DP, Willson K, Thorne SA, Davies LC, Coats AJ. Oxygenation in patients with a functionally univentricular circulation and complete mixing of blood: are saturation and flow interchangeable? Circulation. 1999;100(21):2198-2203. doi:10.1161/01.CIR.100.21.2198. PMID: 10571980.
  3. Graham EM, Bradley SM, Atz AM. Preoperative management of hypoplastic left heart syndrome. Expert Opin Pharmacother. 2005;6(5):687-693. doi:10.1517/14656566.6.5.687. PMID: 15934895.
  4. Hauck A, Porta N, Lestrud S, Berger S. The pulmonary circulation in the single ventricle patient. Children (Basel). 2017;4(8):71. doi:10.3390/children4080071. PMID: 28783102.
  5. Rodefeld MD, Ruzmetov M, Schamberger MS, Girod DA, Turrentine MW, Brown JW. Staged surgical repair of functional single ventricle in infants with unobstructed pulmonary blood flow. Eur J Cardiothorac Surg. 2005;27(6):949-955. doi:10.1016/j.ejcts.2005.01.066. PMID: 15896600.
  6. Kajihara N, Asou T, Takeda Y, Kosaka Y, Onakatomi Y, Nagafuchi H, Yasui S. Pulmonary artery banding for functionally single ventricles: impact of tighter banding in staged Fontan era. Ann Thorac Surg. 2010;89(1):174-179. doi:10.1016/j.athoracsur.2009.09.027. PMID: 20103229.
  7. Ramakrishnan K, Alfares FA, Hammond-Jack K, Endicott K, Nettleton M, Zurakowski D, Jonas RA, Nath DS. Optimal timing of pulmonary banding for newborns with single ventricle physiology and unrestricted pulmonary blood flow. Pediatr Cardiol. 2016;37(3):606-609. doi:10.1007/s00246-015-1321-3. PMID: 26694916.
  8. Alsoufi B, Manlhiot C, Ehrlich A, Oster M, Kogon B, Mahle WT, Maher K, McCrindle BW, Kanter K. Results of palliation with an initial pulmonary artery band in patients with single ventricle associated with unrestricted pulmonary blood flow. J Thorac Cardiovasc Surg. 2015;149(1):213-220. doi:10.1016/j.jtcvs.2014.08.007. PMID: 25190463.
  9. Akintuerk H, Michel-Behnke I, Valeske K, Mueller M, Thul J, Bauer J, Hagel KJ, Kreuder J, Vogt P, Schranz D. Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation. 2002;105(9):1099-1103. doi:10.1161/hc0902.104709. PMID: 11877362.
  10. Galantowicz M, Cheatham JP, Phillips A, Cua CL, Hoffman TM, Hill SL, Rodeman R. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg. 2008;85(6):2063-2070; discussion 2070-2071. doi:10.1016/j.athoracsur.2008.02.009. PMID: 18498821.
  11. Guleserian KJ, Barker GM, Sharma MS, Macaluso J, Huang R, Nugent AW, Forbess JM. Bilateral pulmonary artery banding for resuscitation in high-risk, single-ventricle neonates and infants: a single-center experience. J Thorac Cardiovasc Surg. 2013;145(1):206-213; discussion 213-214. doi:10.1016/j.jtcvs.2012.09.063. PMID: 23244255.
  12. Burkhart HM, Nakamura Y, Salkini A, Schwartz RM, Ranallo CD, Makil ES, Campbell M, Daves SM, Henry ED, Mir A. Bilateral pulmonary artery banding in higher risk neonates with hypoplastic left heart syndrome. JTCVS Open. 2023;16:689-697. doi:10.1016/j.xjon.2023.08.005. PMID: 38204678.
  13. Davies RR, Radtke WA, Klenk D, Pizarro C. Bilateral pulmonary arterial banding results in an increased need for subsequent pulmonary artery interventions. J Thorac Cardiovasc Surg. 2014;147(2):706-712. doi:10.1016/j.jtcvs.2013.10.038. PMID: 24280715.
  14. Iskander C, Nwankwo U, Kumanan KK, Chiwane S, Exil V, Lowrie L, Tan C, Huddleston CB, Agarwal HS. Comparison of morbidity and mortality outcomes between hybrid palliation and Norwood palliation procedures for hypoplastic left heart syndrome: meta-analysis and systematic review. J Clin Med. 2024;13(14):4244. doi:10.3390/jcm13144244. PMID: 39064284.
  15. Callahan CP, Miller P, Carvajal H, Wan F, Canter M, Mannie C, Hill GD, Eghtesady P. Hybrid vs. Norwood: an analysis of the NPC-QIC database to determine optimal approach for high-risk single ventricle patients. Pediatr Cardiol. 2026. doi:10.1007/s00246-026-04166-7. PMID: 41579199.